Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Sleep as a topic in nursing education programs? A mixed method study of syllabuses and nursing students' perceptions.

Gellerstedt L, Medin J, Kumlin M, Rydell Karlsson M.

Nurse Educ Today. 2019 Aug;79:168-174. doi: 10.1016/j.nedt.2019.05.030. Epub 2019 May 23.

PMID:
31132729
2.

Nursing care and management of patients' sleep during hospitalisation: A cross-sectional study.

Gellerstedt L, Medin J, Kumlin M, Rydell Karlsson M.

J Clin Nurs. 2019 Oct;28(19-20):3400-3407. doi: 10.1111/jocn.14915. Epub 2019 Jun 10.

PMID:
31091343
3.

Younger patients and smokers report a higher level of pain after knee arthroscopy: a clinical and experimental study including synovial metabolism.

Berglund L, Stålman A, Dungner E, Qureshi AR, Kumlin M, Felländer-Tsai L.

Knee Surg Sports Traumatol Arthrosc. 2019 Feb;27(2):471-477. doi: 10.1007/s00167-018-5125-x. Epub 2018 Sep 7.

4.

Nurses' experiences of hospitalised patients' sleep in Sweden: a qualitative study.

Gellerstedt L, Medin J, Kumlin M, Rydell Karlsson M.

J Clin Nurs. 2015 Dec;24(23-24):3664-73. doi: 10.1111/jocn.12985. Epub 2015 Sep 15.

PMID:
26373981
5.

The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma.

James A, Daham K, Backman L, Brunnström A, Tingvall T, Kumlin M, Edenius C, Dahlén SE, Dahlén B, Claesson HE.

Int Arch Allergy Immunol. 2013;162(2):135-42. doi: 10.1159/000351422. Epub 2013 Jul 31.

PMID:
23921438
6.

Challenge of isolated sputum cells supports in vivo origin of intolerance reaction to aspirin/non-steroidal anti-inflammatory drugs in asthma.

Higashi A, Kumlin M, Higashi N, Daham K, Gaber F, Lindeberg A, James A, Skedinger M, Delin I, Gyllfors P, Dahlén SE, Dahlén B.

Int Arch Allergy Immunol. 2012;158(3):299-306. doi: 10.1159/000331433. Epub 2012 Mar 6.

7.

Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.

Gaber F, Daham K, Higashi A, Higashi N, Gülich A, Delin I, James A, Skedinger M, Gyllfors P, Nord M, Dahlén SE, Kumlin M, Dahlén B.

Thorax. 2008 Dec;63(12):1076-82. doi: 10.1136/thx.2008.101196. Epub 2008 Aug 29.

PMID:
18757457
8.

Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia.

Roos C, Stenke L, Ohm L, Widell S, Kumlin M, Lindgren JA, Tornhamre S.

Br J Haematol. 2008 Sep;142(6):992-5. doi: 10.1111/j.1365-2141.2008.07283.x. Epub 2008 Jun 28. No abstract available.

PMID:
18573108
9.

Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung.

Selg E, Låstbom L, Ryrfeldt A, Kumlin M, Dahlén SE.

Prostaglandins Leukot Essent Fatty Acids. 2008 Feb;78(2):89-97. doi: 10.1016/j.plefa.2008.01.001.

PMID:
18294831
10.

Expression of 15-lipoxygenase type-1 in human mast cells.

Gulliksson M, Brunnström A, Johannesson M, Backman L, Nilsson G, Harvima I, Dahlén B, Kumlin M, Claesson HE.

Biochim Biophys Acta. 2007 Sep;1771(9):1156-65. Epub 2007 Jun 23.

PMID:
17662651
11.

Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton.

Gaber F, James A, Delin I, Wetterholm A, Sampson AP, Dahlén B, Dahlén SE, Kumlin M.

J Allergy Clin Immunol. 2007 May;119(5):1267-8. Epub 2007 Jan 25. No abstract available.

PMID:
17258303
12.

Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells.

Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M.

Allergy. 2006 Dec;61(12):1473-9.

PMID:
17073880
13.

Saliva is one likely source of leukotriene B4 in exhaled breath condensate.

Gaber F, Acevedo F, Delin I, Sundblad BM, Palmberg L, Larsson K, Kumlin M, Dahlén SE.

Eur Respir J. 2006 Dec;28(6):1229-35. Epub 2006 Sep 13.

14.

Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate.

Gyllfors P, Dahlén SE, Kumlin M, Larsson K, Dahlén B.

J Allergy Clin Immunol. 2006 Jul;118(1):78-83. Epub 2006 May 30.

PMID:
16815141
15.

Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.

Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M.

Eur Respir J. 2006 May;27(5):944-50.

16.

Effect of respirators equipped with particle or particle-and-gas filters during exposure in a pig confinement building.

Sundblad BM, Sahlander K, Ek A, Kumlin M, Olsson M, Larsson K, Palmberg L.

Scand J Work Environ Health. 2006 Apr;32(2):145-53. Erratum in: Scand J Work Environ Health. 2007 Apr;33(2):160.

17.

Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge.

Ihre E, Gyllfors P, Gustafsson LE, Kumlin M, Dahlén B.

Eur Respir J. 2006 Jun;27(6):1152-9. Epub 2006 Mar 1.

18.

Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.

Gyllfors P, Kumlin M, Dahlén SE, Gaber F, Ehrs PO, Dahlén B.

Thorax. 2005 Nov;60(11):902-8. Epub 2005 Jul 29.

19.

Effects of 5-lipoxygenase inhibitor zileuton on airway responses to inhaled swine house dust in healthy subjects.

Larsson BM, Kumlin M, Sundblad BM, Larsson K, Dahlén SE, Palmberg L.

Respir Med. 2006 Feb;100(2):226-37. Epub 2005 Jun 4.

20.

Monitoring mast cell activation by prostaglandin D2 in vivo.

Dahlén SE, Kumlin M.

Thorax. 2004 Jun;59(6):453-5. No abstract available.

21.

Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms.

Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A.

Am J Clin Nutr. 2004 Jun;79(6):935-45. Review.

PMID:
15159222
22.

High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma.

Vachier I, Kumlin M, Dahlén SE, Bousquet J, Godard P, Chanez P.

Respir Med. 2003 Nov;97(11):1225-9.

23.

Evidence of mast cell activation and leukotriene release after mannitol inhalation.

Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M.

Eur Respir J. 2003 Sep;22(3):491-6.

24.

Cysteinyl leukotrienes in porcine acute allergic airway reactions: bronchial and vascular effects.

Sylvin H, Kumlin M, Alving K.

Inflamm Res. 2003 May;52(5):185-90.

PMID:
12813622
25.

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B.

J Allergy Clin Immunol. 2003 May;111(5):1116-21.

PMID:
12743579
26.
27.

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids.

Grootendorst DC, Dahlén SE, Van Den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJ, O'Sullivan S, Kumlin M, Sterk PJ, Roldaan AC.

Clin Exp Allergy. 2001 Mar;31(3):400-8.

PMID:
11260151
28.
29.

Measurement of leukotrienes in humans.

Kumlin M.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S102-6. Review. No abstract available.

PMID:
10673236
30.

Eosinophil markers in childhood asthma.

O'Sullivan S, Kumlin M.

Clin Exp Allergy. 1999 Nov;29(11):1454-6. No abstract available.

PMID:
10520071
31.

Markers of inflammation and bronchial reactivity in children with asthma, exposed to animal dander in school dust.

Lönnkvist K, Halldén G, Dahlén SE, Enander I, van Hage-Hamsten M, Kumlin M, Hedlin G.

Pediatr Allergy Immunol. 1999 Feb;10(1):45-52. Erratum in: Pediatr Allergy Immunol 2000 May;11(2):127.

PMID:
10410917
32.

Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry.

O'Sullivan S, Mueller MJ, Dahlén SE, Kumlin M.

Prostaglandins Other Lipid Mediat. 1999 May;57(2-3):149-65.

PMID:
10410385
33.

Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine.

O'Sullivan S, Dahlen SE, Larsson K, Larsson BM, Malmberg P, Kumlin M, Palmberg L.

Thorax. 1998 Dec;53(12):1041-6.

34.

Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.

O'Sullivan S, Roquet A, Dahlén B, Dahlén S, Kumlin M.

Clin Exp Allergy. 1998 Nov;28(11):1332-9.

PMID:
9824404
35.

Evidence for mast cell activation during exercise-induced bronchoconstriction.

O'Sullivan S, Roquet A, Dahlén B, Larsen F, Eklund A, Kumlin M, O'Byrne PM, Dahlén SE.

Eur Respir J. 1998 Aug;12(2):345-50.

36.

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.

Dahlén B, Nizankowska E, Szczeklik A, Zetterström O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dubé LM, Dahlén SE.

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1187-94.

PMID:
9563738
37.

Can asthma be studied in the urine?

Dahlén SE, Kumlin M.

Clin Exp Allergy. 1998 Feb;28(2):129-33. No abstract available.

PMID:
9515583
38.

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.

Roquet A, Dahlén B, Kumlin M, Ihre E, Anstrén G, Binks S, Dahlén SE.

Am J Respir Crit Care Med. 1997 Jun;155(6):1856-63.

PMID:
9196086
40.

Measurements of leukotrienes in the urine: strategies and applications.

Kumlin M.

Allergy. 1997 Feb;52(2):124-35. Review. No abstract available.

PMID:
9105516
41.

Urinary 9 alpha, 11 beta-PGF2 as a marker of mast cell activation in allergic and aspirin-intolerant asthma.

O'Sullivan S, Dahlén B, Roquet A, Larsson L, Dahlén SE, Kumlin M.

Adv Exp Med Biol. 1997;433:159-62. No abstract available.

PMID:
9561125
43.

Effects of local and systemic budesonide on allergen-induced airway reactions in the pig.

Fornhem C, Dahlbäck M, Kumlin M, Lundberg JM, Alving K.

Br J Pharmacol. 1996 Jun;118(4):989-97.

44.
45.

Allergen-induced late-phase airways obstruction in the pig: mediator release and eosinophil recruitment.

Fornhem C, Kumlin M, Lundberg JM, Alving K.

Eur Respir J. 1995 Jul;8(7):1100-9.

46.

Arachidonic acid metabolism in the human mast cell line HMC-1: 5-lipoxygenase gene expression and biosynthesis of thromboxane.

Macchia L, Hamberg M, Kumlin M, Butterfield JH, Haeggström JZ.

Biochim Biophys Acta. 1995 Jun 27;1257(1):58-74.

PMID:
7599181
47.

Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans.

Kumlin M, Stensvad F, Larsson L, Dahlén B, Dahlén SE.

Clin Exp Allergy. 1995 May;25(5):467-79.

PMID:
7553251
48.

D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation.

Sanderud J, Oroszlàn G, Bjøro K, Kumlin M, Saugstad OD.

J Perinat Med. 1995;23(5):385-93.

PMID:
8606345
49.

Effects of oxygen radicals on cysteinyl leukotriene metabolism and pulmonary circulation in young pigs.

Sanderud J, Kumlin M, Granström E, Saugstad OD.

Eur Surg Res. 1995;27(2):117-26.

PMID:
7781643
50.

Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans.

Dahlén SE, Dahlén B, Kumlin M, Björck T, Ihre E, Zetterström O.

Adv Prostaglandin Thromboxane Leukot Res. 1994;22:155-66. Review. No abstract available.

PMID:
7771330

Supplemental Content

Loading ...
Support Center